PODD
INSULET CORP
Nasdaq: PODD · Acton, MA · Healthcare
$149.01+0.89 (+0.60%)Closed
Market Cap$10.49B
Cash$856.6Mmost recent
Runwayprofitable
P/E (TTM)42.8EPS $3.48
52-Wk Range$130.47 – $346.36
Avg Volume1.3M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$149.01-37.3%
Pipeline

Drug candidates sponsored by INSULET · ClinicalTrials.gov

23 drugs · 23 trials
PhaseDrug / CandidateIndicationsStatusNext CompletionTrials
N/AUnnamed
Type 1 Diabetes
Completed
2017-02past
1
N/AUnnamed
Type 1 Diabetes Mellitus
Completed
2017-04-07past
1
N/AUnnamed
Type1 Diabetes Mellitus
Completed
2019-05-28past
1
N/AUnnamed
Type 1 Diabetes Mellitus
Completed
2020-01-31past
1
N/AUnnamed
Type 1 Diabetes Mellitus
Completed
2020-07-10past
1
N/AUnnamed
Type 1 Diabetes
Completed
2020-09-29past
1
N/AUnnamed
Type 1 Diabetes Mellitus
Completed
2022-01-17past
1
N/AUnnamed
Type 2 Diabetes Mellitus
Completed
2022-03-06past
1
N/AUnnamed
Type 1 Diabetes
Completed
2023-09-14past
1
N/AUnnamed
Diabetes Mellitus
Completed
2024-01-31past
1
N/AUnnamed
Type2 Diabetes
Completed
2024-03-01past
1
N/AUnnamed
Diabetes Mellitus, Type 1
Completed
2024-08-16past
1
N/AUnnamed
Diabetes Mellitus
Completed
2025-09-08past
1
N/AUnnamed
Diabetes Mellitus, Type 1, Type 2
Completed
2025-11-10past
1
N/AUnnamed
Type 2 Diabetes Mellitus
Completed
2026-01-06past
1
N/AUnnamed
Type 2 Diabetes Mellitus
Completed
2026-03-30past
1
N/AUnnamed
Diabetes Mellitus
Completed
2026-05-06past
1
N/AUnnamed
Type 2 Diabetes Mellitus
Recruiting
2026-12-24
1
N/AUnnamed
Type 1 Diabetes+2 more
Recruiting
2026-12-31
1
N/AUnnamed
Type 2 Diabetes Mellitus+1 more
Recruiting
2027-02-22
1
N/AUnnamed
Type 1 Diabetes
Recruiting
2027-06
1
N/AUnnamed
Diabetes+2 more
Active, not recruiting
2027-07-30
1
N/AUnnamed
Diabetes+2 more
Recruiting
2027-11
1
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for PODD. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.